Ruxience 100mg and 500mg Concentrate for Solution for Infusion
- Name:
Ruxience 100mg and 500mg Concentrate for Solution for Infusion
- Company:
Pfizer Healthcare Ireland
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may not be renewed (A)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 22/02/21

Click on this link to Download PDF directly
Pfizer Healthcare Ireland

Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 22 February 2021 PIL
Reasons for updating
- Change to section 4 - how to report a side effect
- Change of distributor details
Updated on 23 December 2020 SPC
Reasons for updating
- Change to Section 4.8 – Undesirable effects - how to report a side effect
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 23 December 2020 PIL
Reasons for updating
- Change to section 4 - how to report a side effect
- Change of distributor details
Updated on 7 September 2020 SPC
Reasons for updating
- Change to section 6.3 - Shelf life
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 1 September 2020 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Product Launch 01-Sept-2020
Updated on 1 September 2020 PIL
Reasons for updating
- New PIL for new product
Free text change information supplied by the pharmaceutical company
Product Launch 01-Sept-2020